These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19186992)

  • 1. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing.
    Shimizu H; Nakagami H; Morita S; Tsukamoto I; Osako MK; Nakagami F; Shimosato T; Minobe N; Morishita R
    Antioxid Redox Signal; 2009 Sep; 11(9):2065-75. PubMed ID: 19186992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption.
    Huang AC; Ishida Y; Li K; Rintanalert D; Hatano-Sato K; Oishi S; Hosomichi J; Usumi-Fujita R; Yamaguchi H; Tsujimoto H; Sasai A; Ochi A; Watanabe H; Ono T
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model.
    Lin TH; Pajarinen J; Sato T; Loi F; Fan C; Córdova LA; Nabeshima A; Gibon E; Zhang R; Yao Z; Goodman SB
    Acta Biomater; 2016 Sep; 41():273-81. PubMed ID: 27260104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
    Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
    Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
    Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound microbubble-mediated transfection of NF-κB decoy oligodeoxynucleotide into gingival tissues inhibits periodontitis in rats in vivo.
    Yamaguchi H; Ishida Y; Hosomichi J; Suzuki JI; Hatano K; Usumi-Fujita R; Shimizu Y; Kaneko S; Ono T
    PLoS One; 2017; 12(11):e0186264. PubMed ID: 29091721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion].
    Fang DQ; Yu T; Wan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats].
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors.
    Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Jo N; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jan; 109(1):132-8. PubMed ID: 14662712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
    Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
    Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression].
    Jiang HL; Xue WJ; Liu H; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury.
    Li JD; Peng Y; Peng XY; Li QL; Li Q
    Transplant Proc; 2010 Jun; 42(5):1582-6. PubMed ID: 20620478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
    Lu JP; Sun H; Cao CC; Ou ZL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
    Wang T; Li QH; Hao GP; Zhai J
    Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.
    Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S
    Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.
    Li YT; He B; Wang YZ; Wang J
    Respir Res; 2009 Aug; 10(1):79. PubMed ID: 19706153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
    Fichtner-Feigl S; Fuss IJ; Preiss JC; Strober W; Kitani A
    J Clin Invest; 2005 Nov; 115(11):3057-71. PubMed ID: 16239967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.